Share Email Print

Proceedings Paper

OCT for lung transplantation monitoring: quantification of chronic lung allograft dysfunction (CLAD) biomarkers (Conference Presentation)
Author(s): Geoffrey Hohert; Anthony Lee M.D.; Sylvia Lam; Pierre M. Lane; Calum MacAulay; Stephen Lam M.D.; Roland Nador M.D.; Robert Levy; John English

Paper Abstract

Chronic Lung Allograft Dysfunction (CLAD) remains a significant cause of morbidity and mortality following lung transplantation. Bronchiolitis obliterans Syndrome (BOS) is a predominant phenotype of CLAD primarily affecting the small and subsequently the large airways leading eventually to graft failure. In addition, the allograft airways are also involved in other types of CLAD such as Restrictive Allograft Syndrome (RAS). Freedom from BOS at five years post-transplant is only approximately 50 % among lung transplant recipients. The diagnosis of CLAD is primarily based on pulmonary function testing and radiographic findings on CT scan. Transbronchial biopsies have a low diagnostic yield due to the multifocal nature of CLAD and the frequent lack of bronchioles in the biopsy specimen. Thus, CLAD is often diagnosed after significant disease progression. We performed endoscopic OCT as a minimally invasive method to identify early CLAD biomarkers. During 65 routine surveillance and event-initiated bronchoscopies of lung transplant recipients at Vancouver General Hospital, OCT imaging was performed prior to acquiring biopsy samples, with multiple 3D volumetric scans taken at locations as close as possible to those biopsied. OCT has the potential to be advantageous over biopsy because multiple airways in the lung can be quickly surveyed. As a first step towards clinical utility we present our methods for quantifying observable biomarkers including luminal size and alveolar density. Ranges of values are established and correlated with airway generation, time since transplant, and infection status.

Paper Details

Date Published: 14 March 2018
Proc. SPIE 10470, Endoscopic Microscopy XIII, 104700A (14 March 2018); doi: 10.1117/12.2291389
Show Author Affiliations
Geoffrey Hohert, BC Cancer Research Ctr. (Canada)
Anthony Lee M.D., BC Cancer Research Ctr. (Canada)
Sylvia Lam, BC Cancer Research Ctr. (Canada)
Pierre M. Lane, BC Cancer Research Ctr. (Canada)
Calum MacAulay, BC Cancer Research Ctr. (Canada)
Stephen Lam M.D., BC Cancer Research Ctr. (Canada)
Roland Nador M.D., Vancouver General Hospital (Canada)
Robert Levy, Vancouver General Hospital (Canada)
John English, Vancouver General Hospital (Canada)

Published in SPIE Proceedings Vol. 10470:
Endoscopic Microscopy XIII
Guillermo J. Tearney M.D.; Thomas D. Wang; Melissa J. Suter, Editor(s)

© SPIE. Terms of Use
Back to Top